Sino-Singapore Pharmaceutical has reached the adjustment stage again, and if the Chinese medicine sector can be integrated, Sino-Singapore Pharmaceutical is also indispensable. Darentang and Lerentang under Sino-Singapore Pharmaceutical are the same as Tongrentang, which are also from

Sino-Singapore Pharmaceutical has reached the adjustment stage again, and if the Chinese medicine sector can be integrated, Sino-Singapore Pharmaceutical is also indispensable.

Like Tongrentang, Darentang and Lerentang under Sino-Singapore Pharmaceutical are also from The Old Shop of Lejia, and they are all time-honored Chinese brands with continuous operation for 100 years. The company's reserve of pharmaceutical resources that can be further developed is extremely rich. Quick-acting heart-saving pills, Shu Brain Xin drop pills, clear throat drops pills, lung clearing anti-inflammatory pills, etc. are well-known traditional Chinese medicines, the company has other product lines, do not need research and development, as long as the marketing work can be revenue can be on the level.

Benefiting from the advent of the aging society of the mainland, the development of the quick-acting heart-saving pill as a large single product will far exceed the growth rate of the past decade in the next few decades. After the stock reform, the company has integrated sales channels, straightened out channels, and avoided the phenomenon of eating large pots of rice, which will drive these products to have a continuous ability to increase volume. Since patients with heart disease need to take medicines for a long time, price is an important factor affecting patients when choosing products. Quick-acting heart-saving pills are low-cost drugs, and compared with the daily cost of compound danshen drop pills and musk heart pills, the company has a price advantage, and the company has also begun to guide the "emergency" to "daily". Compared with other daily medications, it also has a first-aid function and is also a long-term confidential formula, which are unique advantages. In the case of a general sharp rise in the price of traditional Chinese medicine raw materials, the price of quick-acting heart-saving pills has not increased, and the gross profit margin can be controlled at more than 60%, indicating that the company also has an advantage in this piece of discourse. Quick-acting heart-saving pills are assets that can bring huge profits in the long run, and if calculated separately, the valuation given by the market will far exceed the current overall valuation of the company.